Department of Bioengineering, University of Pittsburgh, Pittsburgh, Pennsylvania 15261, USA.
Tissue Eng Part C Methods. 2012 Jan;18(1):54-61. doi: 10.1089/ten.TEC.2011.0216. Epub 2011 Oct 18.
To further differentiate adipose-derived stem cells (ASCs) into mature adipocytes and create three-dimensional (3D) adipose tissue in vitro, we applied multicompartment hollow fiber-based bioreactor technology with decentral mass exchange for more physiological substrate gradients and integral oxygenation. We hypothesize that a dynamic 3D perfusion in such a bioreactor will result in longer-term culture of human adipocytes in vitro, thus providing metabolically active tissue serving as a diagnostic model for screening drugs to treat diabetes. ASCs were isolated from discarded human abdominal subcutaneous adipose tissue and then inoculated into dynamic 3D culture bioreactors to undergo adipogenic differentiation. Insulin-stimulated glucose uptake from the medium was assessed with and without TNF-alpha. 3D adipose tissue was generated in the 3D-bioreactors. Immunohistochemical staining indicated that 3D-bioreactor culture displayed multiple mature adipocyte markers with more unilocular morphologies as compared with two-dimensional (2D) cultures. Results of real-time polymerase chain reaction showed 3D-bioreactor treatment had more efficient differentiation in fatty acid-binding protein 4 expression. Repeated insulin stimulation resulted in increased glucose uptake, with a return to baseline between testing. Importantly, TNF-alpha inhibited glucose uptake, an indication of the metabolic activity of the tissue. 3D bioreactors allow more mature adipocyte differentiation of ASCs compared with traditional 2D culture and generate adipose tissue in vitro for up to 2 months. Reproducible metabolic activity of the adipose tissue in the bioreactor was demonstrated, which is potentially useful for drug discovery. We present here, to the best of our knowledge for the first time, the development of a coherent 3D high density fat-like tissue consisting of unilocular structure from primary adipose stem cells in vitro.
为了进一步将脂肪来源干细胞 (ASCs) 分化为成熟脂肪细胞,并在体外创建三维 (3D) 脂肪组织,我们应用了具有分散质量交换的多腔中空纤维基生物反应器技术,以实现更生理的基质梯度和整体氧合。我们假设,在这种生物反应器中进行动态 3D 灌注将导致体外人类脂肪细胞的长期培养,从而提供代谢活跃的组织,作为筛选治疗糖尿病药物的诊断模型。从废弃的人类腹部皮下脂肪组织中分离出 ASCs,然后接种到动态 3D 培养生物反应器中进行成脂分化。评估了有和没有 TNF-α 的情况下,胰岛素刺激的培养基中葡萄糖摄取。在 3D 生物反应器中生成 3D 脂肪组织。免疫组织化学染色表明,与二维 (2D) 培养相比,3D 生物反应器培养显示出多个成熟脂肪细胞标志物,具有更多的单室形态。实时聚合酶链反应的结果表明,3D 生物反应器处理在脂肪酸结合蛋白 4 表达方面具有更高的分化效率。重复胰岛素刺激导致葡萄糖摄取增加,测试之间恢复到基线。重要的是,TNF-α 抑制葡萄糖摄取,表明组织的代谢活性。3D 生物反应器允许 ASCs 比传统的 2D 培养更成熟的脂肪细胞分化,并在体外生成长达 2 个月的脂肪组织。证明了生物反应器中脂肪组织的可重复代谢活性,这对于药物发现具有潜在的用途。我们在此首次展示了从原代脂肪干细胞在体外构建具有单室结构的一致 3D 高密度脂肪样组织的发展。